Clinical Trial

High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated February 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
High-intensity laser therapy has gained increasing attention in recent years as a therapeutic modality. It is a non-invasive treatment that can reduce pain, increase local blood circulation, and promote tissue repair. The higher energy output of high-intensity laser therapy also have deeper tissue penetration. Several studies have investigated the effects of high-intensity laser therapy on lateral epicondylitis, and the existing literature indicates that, compared with other treatment modalities, high-intensity laser therapy is more effective in improving pain and quality of life in patients with lateral epicondylitis. However, the dosage, duration, and treatment frequency applied in previous studies vary considerably. The therapeutic effects of high-intensity laser therapy may therefore be influenced by treatment dosage. Consequently, the purpose of this study is to compare the effects of two different dosages of high-intensity laser therapy on patients with lateral epicondylitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-13.
Trial Details
NCT Number NCT07342426
Lead Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions Lateral Epicondylitis, High Intensity Laser Therapy, Tennis Elbow, High Intensity Laser
Enrollment 45 participants
Start Date 2026-01-12
Primary Completion 2026-02-06 (estimated)
Study Completion 2026-12-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-21